Cibc World Markets Corp Boosts Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Cibc World Markets Corp grew its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 15.2% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 282,286 shares of the pharmacy operator's stock after buying an additional 37,141 shares during the quarter. Cibc World Markets Corp's holdings in Walgreens Boots Alliance were worth $2,634,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of WBA. First Financial Corp IN grew its position in Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after buying an additional 885 shares during the period. Golden State Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth approximately $26,000. Riverview Trust Co increased its stake in shares of Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after purchasing an additional 1,590 shares during the last quarter. Venturi Wealth Management LLC purchased a new position in Walgreens Boots Alliance in the fourth quarter valued at approximately $28,000. Finally, TD Private Client Wealth LLC grew its holdings in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock valued at $29,000 after purchasing an additional 3,208 shares during the period. Hedge funds and other institutional investors own 58.59% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Royal Bank of Canada boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research note on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a "hold" rating to a "sell" rating and lowered their price objective for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Truist Financial cut their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research report on Friday, January 31st. Bank of America upped their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research note on Monday, January 13th. Finally, StockNews.com began coverage on shares of Walgreens Boots Alliance in a report on Tuesday, March 18th. They issued a "hold" rating for the company. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Price Performance

Shares of WBA stock traded down $0.03 on Tuesday, reaching $11.12. The company's stock had a trading volume of 7,770,365 shares, compared to its average volume of 20,772,329. The company has a market capitalization of $9.61 billion, a P/E ratio of -1.09, a PEG ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $22.05. The stock's 50 day simple moving average is $10.94 and its 200-day simple moving average is $9.85. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion for the quarter, compared to analysts' expectations of $37.40 billion. During the same quarter last year, the firm posted $0.66 EPS. The company's revenue was up 7.6% compared to the same quarter last year. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.